Arkolith/Insider Trading/LXRX/Form 4

Artal Participations S.a r.l.

Director, 10% OwnerLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed May 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2026Option exercise(M)20.4M—$0175.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 30, 2026Grant(A)408K——408K
Apr 30, 2026Option exercise(M)408K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-215297) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML